Month: July 2021

Ibogaine Attracts Addiction Research

Researchers continue to examine the therapeutic properties of ibogaine as it proves effective in addiction rehabilitation. Countries such as New Zealand, Brazil, and South Africa allow it for medical use. In the United States, ibogaine is a Schedule 1 substance, which means it is not approved for medical use.  Ibogaine is an indole alkaloid produced by the Taberna iboga shrub native to West Africa. Traditionally, consumers used the substance to reduce fever, boost sexual arousal, and improve health. Specifically, it …

Read MoreIbogaine Attracts Addiction Research

The Promise of Ibogaine

Traditional rehabilitative models are failing to deliver results to those trying to beat chronic drug abuse. Some are hailing the increasing popular extract ibogaine for its suppressive effects on withdrawal symptoms and ultimately, addiction. Ibogaine, derived from a central west African shrub, is a psychedelic drug that has proven effective in treating alcohol, heroin, and opioid addiction in treatment centers worldwide. Scientists continue to study ibogaine to unlock its therapeutic power. One theory researchers have for ibogaine’s effectiveness is that …

Read MoreThe Promise of Ibogaine